Bugal, Dave Enadrin .
HRN: 08-47-99 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/04/2022
CEFIXIME 100MG/5ML, 60ML SUSPENSION (BOT)
12/04/2022
12/11/2022
IV
5mL
BID
URTI
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes